Senior insider sale
Chief Business Officer at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$1.86M
29.17K shares
What this filing means
KREMPA DAVID plans to sell 29.17K shares of ETON PHARMACEUTICALS, INC. valued at approximately $1.86M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/6/2026ACC: 0001974078-26-000377
Officer· Chief Business Officer
Since Mar 2023
29.17K
Shares to sell
$1.86M
Approx. market value
10.52K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
RSU Vest
Cash
10/2/2026
10.52KTotal acquired10.52K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/2/2026 | RSU Vest Cash | 10.52K | — |
| Total | 10.52K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
25K
Market value
$1.63M
8/24/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
4.17K
Market value
$229.4K
10/6/2026
Total
Units
29.17K
Value
$1.86M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/24/2026 | 25K | $1.63M | — | Completed |
| Planned — Approximate Date | ||||
10/6/2026 | 4.17K | $229.4K | Nasdaq | Planned |
| Total | 29.17K | $1.86M | ||